Nectar Lifesciences NECLIFE.NS · INR

Its shares trade on NSE under the ticker NECLIFE.NS. It has been listed since 19 July 2005. In the fiscal year to 31 March 2025, it reported revenue of ₹16.70bn and a net loss of ₹1.14bn. At that date it held total assets of ₹20.47bn and shareholders' equity of ₹9.56bn.

Nectar Lifesciences Ltd. is a holding company, which engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The company went IPO on 2005-07-19. The firm's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The firm is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The firm offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Sanjiv GoyalExecutive Chairman of the Board, Managing Director₹19.9m
• Mr. Amit ChadahChief Executive Officer
• Mr. Sushil KapoorChief Financial Officer
• Mr. Puneet SudAdditional Director, Wholetime Director - Operations, since 2022
• Dr. Indu KaurAdditional Independent (Woman) Director
• Dr. Kuldip BhasinIndependent Non-Executive Director₹80,000
• Dr. Rupinder TewariIndependent Non-Executive Director₹114,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.